Yves here. This post presents a complicated but revealing tale of how a potentially superior and less invasive and risky treatment for clots that cause heart attacks and strokes has gone nowhere. Its inventor believes profit incentives play a major role. By Lynn Parramore, senior research analyst…
Continue reading...